Beyond Method Transfer: How Opella Is Modernizing and Harmonizing LC Methods

As analytical demands keep increasing, the number of samples continues to rise, and regulatory expectations continually evolve, legacy HPLC methods can severely limit productivity and drive-up costs in pharmaceutical and other regulated laboratories.
Through a process called method modernization, labs can expand analytical capacity to better support evolving laboratory and business needs.
To be successful, modernization requires a structured approach that balances, speed, method performance, validation, compliance and transfer across sites with different capabilities.
At the Opella site in Compiègne/France this approach delivered measurable results. In one modernization project, two separate methods were consolidated into a single UHPLC method, reducing total analytical run time by 91% while also lowering solvent consumption and laboratory costs.
Want to learn how your lab can achieve similar time and cost savings through modernization?
Join our webinar with Opella to explore their ongoing modernization journey, from accelerating legacy methods and validating methods for new product formulations to harmonizing and transferring methods across sites.
Discover how a systematic, stepwise modernization strategy can help reduce analytical burden today while creating greater flexibility for future laboratory needs.
Learning Objectives:
- Identify where method modernization can deliver meaningful productivity gains
- Balance faster methods with performance, validation, and regulatory requirements
- Plan method harmonization and transfer across sites with different HPLC and UHPLC capabilities
Who should attend?
- Analytical and Method Development Scientists
- Pharmaceutical QC and QA Professionals
- Analytical Lifecycle Management Teams
- CMC and Regulatory Scientists
- Laboratory Managers and Directors
- Scientists responsible for method validation, transfer, and ongoing method performance monitoring
Register now and learn how to support evolving laboratory needs through method modernization.
Presenter: Marion Lincker (Head of Analytical Development, Opella)
As Head of Analytical Development at Opella, Marion Lincker leads activities focused on the development, optimization, and validation of analytical methods for pharmaceutical products, with a strong emphasis on HPLC. A trained chemical engineer, she has dedicated her career to analytical method development, beginning at Organon with assay and impurity profiling of active pharmaceutical ingredients. She then spent more than 20 years at Sanofi and later Opella, where she specialized in assay and impurity methods for finished pharmaceutical products. Her HPLC expertise spans method development, validation, method transfer, robustness studies, and regulatory compliance, making her a key contributor to product quality and innovation in analytical sciences.
Presenter: Vincent Lelièvre (Business Development Specialist, Thermo Fisher Scientific )
Vincent Lelièvre is a Business Development Specialist at Thermo Fisher Scientific. He holds a Master’s degree in Analytical Chemistry and has a strong interest in helping customers address their evolving analytical and business challenges. His primary focus is on understanding customer needs and supporting them in preparing for future requirements through innovative solutions and a long-term perspective.
